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As liver tumours receive some of their blood supply from the portal vein, we wanted to illustrate
the influence of portal blood flow in combination with dearterialization in the treatment of liver
tumours. Forty male, inbred Wistar/Furth rats with an adenocarcinoma transplanted to the liver
were treated with various inflow occlusions repeated daily for 5 days. Deviation of the portal
blood flow alone with an end-side porto-caval shunt did not alter the tumour growth (p 0.089).
Thirty min of repeat dearterializations was potentiated by portal deviation so that tumour
growth was delayed (p 0.004). However, repeat dearterializations for 60 min in portal deviated
rats induced irreversible liver damage and all rats died in a few days. Repeated dearterializations
for 60 minutes alone retarded the tumour growth as efficiently (p =0.007). Simultaneous
occlusion of the hepatic artery and the portal vein for 30 minutes with a side-side porto-caval
shunted (total devascularization) did not affect tumour growth (p 0.154). Liver aminotran-
sferases (ASAT and ALAT) were substantially increased following dearterialization for 30 min in
rats with either an end-side or a side-side porto-caval shunt. Dearterialization for 60 min in rats
with end-side porto-caval shunts gave a further release of ASAT and ALAT.
In conclusion, portal deviation did not augment the therapeutic benefit of repeat dearteriali-
zations for the treatment of this experimental liver tumour. Repeat dearterializations alone
seemed to be a feasible and efficient therapy for liver tumours.
KEY WORDS: Ischemia dearterialization liver tumour porto-caval shunt
INTRODUCTION
The theory that established liver tumours are predomi-
nantly supplied from the hepatic artery1-’ has led to
extensive use of hepatic artery ligation (HAL), deart-
erialization and cytotoxic perfusion through the hepa-
tic artery in the treatment of both primary and second-
ary malignant liver tumours. Some studies have shown
that small liver tumours and tumour cells in the periph-
eral zone are supplied from both the hepatic artery
and the portal vein5’6. Intra portal chemotherapy
has been tried as portal blood flow has been shown
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to significantly increase following HAL7. Further-
more, a favourable response to repeat dearterializ-
ations was observed in hepatocellular carcinoma
(HCC) patients with an obstructed portal vein8 sug-
gesting that portal blood flow to the tumour might
play a role during ischemic treatment of liver tumours.
This experiment was designed to find out whether
occlusion of both portal and hepatic arterial blood
flow was more efficient in retarding the growth of
a liver, tumour than either alone and also to study the
injurious effects ofsuch procedures on the normal liver.
A porto-caval shunt was used to deprive the tumour of
its portal supply and the hepatic artery was intermit-
tently and briefly occluded with an implantable oc-
cluder as described previously9.
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MATERIALS AND METHODS
Male inbred Wistar/Furth (W/F) rats weighing 200-
300 g were used. They were housed three per cage and
fed standard laboratory diet ad libitum. The tumour
used was a N-methyl-N-nitrosoguanidine-induced
colonic adenocarcinoma propagated intraperitoneally
by weekly injections1. The number of passages before
the generation used in this study was3. Under chloral-
hydrate (0.25 g/kg; Apoteksbolaget, Stockholm, Swe-
den) anaesthesia the abdominal cavity was opened
through a midline incision and a suspension contain-
ing 1 x 106 viable tumour cells was injected subcap-
sularly into the left lobe of the liver. Five days after
inoculation the tumours were measured with callipers
and the rats randomly allocated to the various treat-
ment groups. Creation of a porto-caval shunt (end-side
or side-side) and implantation of the occluder were
performed at the same laparotomy. On the sixth day
after treatment all rats were killed with ether, the
tumours remeasured and their volumes calculated ac-
cording to the formula: V= axb2/2 (a the longest
and b the shortest diameter of the tumour)11.
Forty rats were randomly assigned to one of
7 groups:
Group A: Sham-operated control (n 6);
Group B: Deviation of portal blood flow with an
end-side portacaval shunt (n 6);
Group C: Repeated simultaneous occlusion of both
the hepatic artery and the portal vein (total
devascularization) for 30 minutes daily
with a side-side portacaval shunt (n 6);
Group D: Repeated dearterializations for 30 minutes
daily with an end-side portacaval shunt
(n 6);
Group E: Repeated dearterializations for 60 minutes
daily with an end-side portacaval shunt
(n 4);
Group F: Repeated dearterializations for 30 minutes
daily (n 6);
Group G: Repeated dearterializations for 60 minutes
daily (n 6).
The surgical procedures were as follows. The portal
vein was mobilized from the hepatic artery and tran-
sected as close to the hilum as possible. The inferior
vena cava was then mobilizedjust above the right renal
vein without posterior dissection. An angled vascular
clamp was placed across a segment ofthe anteromedial
wall of the inferior vena cava and an end-side porto-
caval anastomosis was created With 8/0 silk. A side-side
porto-caval anastomosis was created after mobiliz-
ation of the portal vein and the inferior vena cava. The
inferior vena cava was entirely freed from its surround-
ings above the right renal vein up to the liver and the
portal vein likewise isolated to prevent tension of the
anastomosis. Intermittent dearterializations were
achieved with the use of an implantable occluder as
previously described9. In short, the hepatoduodenal
ligament and all the attachments to the liver were
dissected and ligated including the esophageal arterial
branch and the right gastric artery. The sleeves of the
minioccluder were sewn together around the hepatic
artery in group D, E, F and G and around both the
hepatic artery and the portal vein in group C. The
silicone tube from the minioccluder was taken out
subcutaneously and fixed behind the neck of the rat.
Occlusions were performed by inflating the balloon
with about 0.06-0.08ml saline once a day during
5 days.
Release of aspartate-aminotransferase (ASAT) and
alanine-aminotransferase (ALAT) were used as indi-
cators of liver damage and measured separately in
another 18 male Sprague-Dawley rats which were
divided into 3 groups: A end-side porto-caval shunt
with transient dearterialization for 30 minutes (n 6);
B end-side porto-caval shunt with transient dear-
terialization for 60 minutes (n=6); C=side-side
porto-caval shunt with transient occlusion of both the
portal vein and hepatic artery for 30 minutes. Blood
samples were taken at 1, 2, 8 and 24 hours after
reperfusion. ASAT and ALAT were analyzed accord-
ing to the committee on enzymes of the Scandinavian
Society for clinical chemistry and clinical physiology12
and compared to ASAT and ALAT in normal rats,
O (n= 6).
Statistics: Kruskal Wallis and Mann-Whitney U test
were used for statistical evaluation of tumour growth
delay. Significant differences of ASAT and ALAT were
assessed with One-way ANOVA.
RESULTS
By the 6th day all tumours were visible under the liver
capsule as a well defined grey nodule. At the beginning
of the treatment the rats appeared disturbed when the
balloon was inflated and deflated but they soon be-
came accustomed to the procedure and occlusions were
well tolerated. Tumour volumes and body weights
before and after treatment are shown in Table 1. Body
weights did not differ significantly between the various
treatment groups including sham treated controls
(p 0.187 Kruskal Wallis test).
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Figure Tumour volume ratio (1/’6/1/’o) after 5 days of treatment.
A control; B deviation of portal blood flow alone; C repeated
total devascularizations for 30 minutes with a side-side porto-caval
shunt; D repeated dearterializations for 30 minutes with an end-
side portocaval shunt; E repeated dearterializations for 30 minutes
and F repeated dearterializations for 60 minutes alone. **p < 0.01
compared with A. Values are median and range.
Figure 1 shows differences in tumour growth among
groups. Treatments had a significant effect on tumour
growth (p=0.0012 Kruskal Wallis test), but portal
deviation alone (group B) did not influence the tumour
growth as compared with no treatment (p 0.089),
indicating a non-significant contribution by portal
blood to the growth of the tumours. If an end-side
porto-caval shunt was combined with repeated dearte-
rializations for 30 minutes (group D) tumour growth
was significantly delayed in comparison with no treat-
ment (p 0.004). Daily dearterializations for 60 mi-
nutes in rats having an end-side porto-caval .shunt
effectively retarded the tumour growth (group E) as
shown in Table 1; however, all the rats died by the 4th
day due to severe liver damage. Repeated dearterializ-
ations for 60 minutes alone was equally efficient in
retarding tumour growth as an end-side porto-caval
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Figure 2A-2B ASAT (2A) and ALAT (2B) at different time periods
after reperfusion (mean _+ SEM). ASAT and ALAT were released
immediately (p < 0.05) after reperfusion and showed a tendency to
recover in porto-caval shunt rats dearterialized for 30 min. They had
returned to normal 24 hours after reperfusion (p > 0.05). Whereas,
the maximum release of ASAT and ALAT in rats with an end-side
porto-caval shunt subjected to 60 min of dearterialization was at
2 hours and they did not restore to normal even 24 hours after
reperfusion (p < 0.05).
Table 1 Tumour volumes and body weights before and after 5 days of treatment (mean + SEM).
A B C D E* F G
Tumour volume (mm2)
Pre-treatment 25.00+ 12.63 15.29+ 5.29 16.87+ 2.82 17.27+ 6.77 9.72 + 4.53 39.71+ 11.87 50.81+21.97
Post-treatment 147.72 +49.84 140.04+ 27.84 84.77_ 723 38.15_ 8.39 6.93 + 2.75 114.49__+ 39.59 394.31 65.09
Body weight (g)
Pre-treatment 288.67 + 12.22 294.66_ 5.30 283.16_ 9.25 269.16 + 12.78 286.75 + 19.38 270.66_+ 10.23 299.33 + 4.74
Post-treatment 277.33___ 11.40 274.66+ 4.82 251.50+ 10.50 242.33+ 10.78 256.75+ 22.78 245.33+ 11.58 271.67 +_ 6.37
A: Control; B: Deviation of portal blood flow; C: Repeated simultaneous occlusions of both the hepatic artery and the portal vein for 30
minutes with side-side porto-caval shunt; D: Repeated dearterializations for 30 minutes with an end-side porto-caval shunt; E: Repeated
dearterializations for 60 minutes in rats with an end-side porto-caval shunt (all the rats died by the 4th day; *: tumour volumes and body
weights at death of the rats; F: Repeated dearterializations for 30 minutes; G: Repeated dearterializations for 60 minutes.
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shunt with dearterializations for 30 minutes (p 0.007
vs. control). A side-side porto-caval shunt combined
with occlusions of both the portal vein and the hepatic
arterial circulation for 30 minutes was not as effective
as end-side porto-caval shunt to retard the tumour
growth (p 0.154 vs. control). Tumour growth seemed
to be increased following intermittent dearterializ-
ations for 30 minutes alone, but the growth rate was
not significantly higher than no treatment (p 0.294).
Figure 2 shows the release ofaminotransferases after
different periods of total vascular inflow occlusion.
End-side porto-caval shunt with arterial occlusion and
side-side porto-caval shunt with occlusion of both the
artery and the portal vein for 30 minutes produced
a maximum release of ASAT and ALAT within 1 hour
,after reperfusion, but gradually normalized within
24 hours. Extending the vascular obstructions to 60
minutes in rats having an end-side porto-caval shunt
resulted in a progressive release of ASAT and ALAT
that didnot normalize before the next dearterialization
started. All the animals in this group died within 4 days
indicating severe liver damage.
DISCUSSION
This study has shown that deviation of the portal
blood by a portocaval shunt did not reduce the growth
of an implanted liver tumour. However, by the addi-
tion of repeated dearterializationsfor 30 minutes the
tumour growth was significantly retarded. Extending
dearterializations to 60 minutes further reduced
tumour growth hut all rats died after four treatments.
On the other hand, repeated dearterializations for 60
minutes alone without deviation of the portal blood
was as efficient in retarding the tumour growth as
repeated dearterializations for 30 minutes in combina-
tion with portal deviation. Repeated normothermic
total ischemia for 30 minutes gave rise to a reversible
liver injury but extending the ischemic time to
60 minutes caused progressive liver damage.
Responses of liver tumours to intermittent dearte-
rialization have been demonstrated experimentally
and clinically8’9’13-16, though the role of the portal
contribution to the tumour during dearterialization is
still unsolved. It has been demonstrated that massive
tumours have a wide variety of vascular patterns:
predominantly arterial, predominantly portal or
a mixture of both systems 17’1a. On the other hand the
portal supply to liver tumours changes during obstruc-
tion of the hepatic artery. A significant increase in
portal flow following HAL has been shown to occur
both in experimental animals and in patients with liver
tumours7’19’2. Moreover, two patients with an ob-
structed portal vein responded to repeat dearterializ-
ations with full remission in one patient and partial
regression of tumour size and -fetoprotein in another
patienta. This might indicate that portal blood, al-
though it does not alter tumour growth when applied
alone, may to some extent play a role during dearterial-
ization. As revealed in this study, tumour growth was
significantly retarded after 5 days of repeat dearterial-
izations for 30 minutes in rats with an end-side
porto-caval shunt. Prolonging dearterializations to 60
minutes seemed not to further reduce the umour as
compared with dearterializations for 30 minutes in the
rats with a porto-caval shunt. It seemed that repeat
dearterializations were potentiated by portal devi-
ation. However, it remains unclear whether tumour
regression was due to the antitumour effect of dear-
terialization combined with portal deviation or
cachexia since serious liver injury was induced in all
rats following repeat dearterializations in combination
with portal deviation. The rats died within 4 days
following 60 minutes of daily dearterializations with
portal deviation. In contrast, repeat dearterializations
alone for 60 minutes was as efficient in retarding
tumour growth without any notable injury to normal
liver tissues. Thus, the same growth delay as was seen
after 30 minutes of repeat dearterializations in combi-
nation with portal deviation was achieved with simple
repeat-dearterializations for 60 minutes alone. As we
have demonstrated before, repeat dearterializations
can be performed for as long as 3 or 4 hours without
a significant increase of aminotransferases21. This
means that repeat dearterializations are selectively
cytotoxic to the tumours sparing the normal liver
parenchyma.
The main conclusion from this study is that portal
deviation during dearterialization seems more harm-
ful than beneficial. If performed long enough repeat
dearterializations alone are as effective to delay tu-
mour growth, but less injurious to the liver9. This
knowledge may have clinical implications in patients
who have portal vein obstructed by a liver tumour. In
these patients dearterialization, when considered,
should be delivered as short repeated occlusions.
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